Frank Curzio and Scot Cohen, Curzio One Wealth Forum
Frank Curzio and Scot Cohen, Curzio One Wealth Forum

This week's trade

Biotech is always risky—but when valuations collapse, the risk/reward can swing aggressively in investors’ favor.

That’s the case with one tiny biotech that has been completely left for dead…

This company has a breakthrough immuno-oncology platform… multiple drugs advancing through the pipeline… and a massive total addressable market.

At today’s depressed valuation, any positive news could send the stock soaring. In fact, we could see 10x gains.

Join Wall Street Unplugged Premium for full analysis and ticker symbol